...
search icon
asmb-img

Assembly Biosciences Inc, Common Stock

ASMB

NSQ

$13.52

-$0.04

(-0.29%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$102.50M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
2.41K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.50
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$7.75 L
$19.93 H
$13.52

About Assembly Biosciences Inc, Common Stock

Assembly Biosciences, Inc., a biotechnology company, develops therapeutic candidates for the treatment of viral diseases worldwide. Its pipeline includes long-acting helicase-primase inhibitors candidates, including ABI-5336 and ABI-1179, which are in Phase 1a/1b clinical studies for recurrent genital herpes; ABI-4334, a capsid assembly modulator designed to disrupt the replication cycle of hepatitis B virus that is in Phase 1b clinical study; and ABI-6250, an orally bioavailable hepatitis delta virus entry inhibitor that is in Phase 1a clinical study. The company also develops ABI-7423, an oral broad-spectrum non-nucleoside polymerase inhibitor that targets transplant-related herpesviruses. It has an option, license, and collaboration agreement with Gilead Sciences, Inc. for the research and development of virology therapies. The company was formerly known as Ventrus Biosciences, Inc. and changed its name to Assembly Biosciences, Inc. in June 2014. Assembly Biosciences, Inc. was incorporated in 2005 and is headquartered in South San Francisco, California. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameASMBSectorS&P500
1-Week Return0.75%-1.91%-1.87%
1-Month Return29.88%-3.82%8.93%
3-Month Return7.73%-11.56%-2.39%
6-Month Return-8.71%-10.21%-2.41%
1-Year Return-8.34%-9.91%10.88%
3-Year Return-30.88%-0.28%46.93%
5-Year Return-94.41%31.29%94.89%
10-Year Return-92.62%75.9%177.5%

Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue79.11M6.25M-7.16M28.52M[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":7.91,"profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":9.06,"profit":true},{"date":"2024-12-31","value":36.05,"profit":true}]
Cost of Revenue101.34K466.00K498.00K48.90M129.00K[{"date":"2020-12-31","value":0.21,"profit":true},{"date":"2021-12-31","value":0.95,"profit":true},{"date":"2022-12-31","value":1.02,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":0.26,"profit":true}]
Gross Profit79.00M5.79M(498.00K)(41.74M)28.39M[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":7.33,"profit":true},{"date":"2022-12-31","value":-0.63,"profit":false},{"date":"2023-12-31","value":-52.83,"profit":false},{"date":"2024-12-31","value":35.94,"profit":true}]
Gross Margin99.87%92.55%(Infinity%)(582.67%)99.55%[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":92.67,"profit":true},{"date":"2022-12-31","value":null,"profit":false},{"date":"2023-12-31","value":-583.42,"profit":false},{"date":"2024-12-31","value":99.68,"profit":true}]
Operating Expenses143.88M97.30M94.11M71.81M73.94M[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":67.63,"profit":true},{"date":"2022-12-31","value":65.41,"profit":true},{"date":"2023-12-31","value":49.91,"profit":true},{"date":"2024-12-31","value":51.39,"profit":true}]
Operating Income(64.78M)(132.69M)(94.11M)(64.65M)(45.42M)[{"date":"2020-12-31","value":-6477600000,"profit":false},{"date":"2021-12-31","value":-13268800000,"profit":false},{"date":"2022-12-31","value":-9411400000,"profit":false},{"date":"2023-12-31","value":-6464600000,"profit":false},{"date":"2024-12-31","value":-4542000000,"profit":false}]
Total Non-Operating Income/Expense5.25M604.00K2.04M5.86M11.15M[{"date":"2020-12-31","value":47.08,"profit":true},{"date":"2021-12-31","value":5.42,"profit":true},{"date":"2022-12-31","value":18.34,"profit":true},{"date":"2023-12-31","value":52.6,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Pre-Tax Income(62.15M)(132.39M)(93.09M)(61.20M)(39.85M)[{"date":"2020-12-31","value":-6215200000,"profit":false},{"date":"2021-12-31","value":-13238600000,"profit":false},{"date":"2022-12-31","value":-9309200000,"profit":false},{"date":"2023-12-31","value":-6119500000,"profit":false},{"date":"2024-12-31","value":-3984700000,"profit":false}]
Income Taxes(2.62M)(2.53M)(1.02M)33.00K330.00K[{"date":"2020-12-31","value":-795.15,"profit":false},{"date":"2021-12-31","value":-766.97,"profit":false},{"date":"2022-12-31","value":-309.7,"profit":false},{"date":"2023-12-31","value":10,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Income After Taxes(59.53M)(129.85M)(92.07M)(61.23M)(40.18M)[{"date":"2020-12-31","value":-5952800000,"profit":false},{"date":"2021-12-31","value":-12985500000,"profit":false},{"date":"2022-12-31","value":-9207000000,"profit":false},{"date":"2023-12-31","value":-6122800000,"profit":false},{"date":"2024-12-31","value":-4017700000,"profit":false}]
Income From Continuous Operations(62.15M)(129.85M)(93.09M)(72.66M)(40.18M)[{"date":"2020-12-31","value":-6215200000,"profit":false},{"date":"2021-12-31","value":-12985500000,"profit":false},{"date":"2022-12-31","value":-9309200000,"profit":false},{"date":"2023-12-31","value":-7266100000,"profit":false},{"date":"2024-12-31","value":-4017700000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income(59.53M)(129.85M)(92.07M)(61.23M)(40.18M)[{"date":"2020-12-31","value":-5952800000,"profit":false},{"date":"2021-12-31","value":-12985500000,"profit":false},{"date":"2022-12-31","value":-9207000000,"profit":false},{"date":"2023-12-31","value":-6122800000,"profit":false},{"date":"2024-12-31","value":-4017700000,"profit":false}]
EPS (Diluted)(1.62)(2.03)(1.93)(3.11)(6.79)[{"date":"2020-12-31","value":-162,"profit":false},{"date":"2021-12-31","value":-203,"profit":false},{"date":"2022-12-31","value":-193,"profit":false},{"date":"2023-12-31","value":-311,"profit":false},{"date":"2024-12-31","value":-679,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

ASMB
Cash Ratio 1.95
Current Ratio 2.05

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

ASMB
ROA (LTM) -25.49%
ROE (LTM) -133.65%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

ASMB
Debt Ratio Lower is generally better. Negative is bad. 0.73
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.27

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

ASMB
Trailing PE NM
Forward PE NM
P/S (TTM) 3.21
P/B 3.81
Price/FCF NM
EV/R 0.47
EV/Ebitda 0.42
PEG NM

FAQs

What is Assembly Biosciences Inc share price today?

Assembly Biosciences Inc (ASMB) share price today is $13.52

Can Indians buy Assembly Biosciences Inc shares?

Yes, Indians can buy shares of Assembly Biosciences Inc (ASMB) on Vested. To buy Assembly Biosciences Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in ASMB stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Assembly Biosciences Inc be purchased?

Yes, you can purchase fractional shares of Assembly Biosciences Inc (ASMB) via the Vested app. You can start investing in Assembly Biosciences Inc (ASMB) with a minimum investment of $1.

How to invest in Assembly Biosciences Inc shares from India?

You can invest in shares of Assembly Biosciences Inc (ASMB) via Vested in three simple steps:

  • Click on Sign Up or Invest in ASMB stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Assembly Biosciences Inc shares
What is Assembly Biosciences Inc 52-week high and low stock price?

The 52-week high price of Assembly Biosciences Inc (ASMB) is $19.93. The 52-week low price of Assembly Biosciences Inc (ASMB) is $7.75.

What is Assembly Biosciences Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Assembly Biosciences Inc (ASMB) is 3.81

What is the Market Cap of Assembly Biosciences Inc?

The market capitalization of Assembly Biosciences Inc (ASMB) is $102.50M

What is Assembly Biosciences Inc’s stock symbol?

The stock symbol (or ticker) of Assembly Biosciences Inc is ASMB

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top